Update shared on21 Sep 2025
Fair value Increased 2.10%The consensus analyst price target for JD Health International has edged higher, primarily driven by a notable increase in the forecast Future P/E multiple despite nearly unchanged revenue growth expectations, resulting in a new target of HK$67.22.
What's in the News
- Upcoming board meeting to review and approve unaudited interim results for the six months ended June 30, 2025.
- Board will consider recommending payment of an interim dividend.
Valuation Changes
Summary of Valuation Changes for JD Health International
- The Consensus Analyst Price Target has risen slightly from HK$65.84 to HK$67.22.
- The Future P/E for JD Health International has risen from 34.41x to 37.85x.
- The Consensus Revenue Growth forecasts for JD Health International remained effectively unchanged, moving only marginally from 14.7% per annum to 14.8% per annum.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.